Login / Signup

Brain 11 C-ITMM PET to longitudinally assess type 1 metabotropic glutamate receptor availability in Alzheimer's disease.

Kenji IshibashiYoshiharu MiuraKei WagatsumaMasashi KameyamaKenji Ishii
Published in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2021)
This study suggests that mGluR1 availability is unchanged in the follow-up period of a few years during the early-to-middle stages of AD.
Keyphrases
  • computed tomography
  • white matter
  • resting state
  • cognitive decline
  • positron emission tomography
  • multiple sclerosis
  • binding protein
  • brain injury
  • mild cognitive impairment